Hims & Hers Health, INC Form 4 insider transactions

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,334 shares of Class A Common Stock at a price of $17.3 per share on August 6, 2024.

CEO Andrew Dudum exercised stock options and sold shares of Hims & Hers Health, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Melissa Baird, COO of Hims & Hers Health, executed stock option exercises and sales of Class A Common Stock between August 5th and August 7th, 2024, according to a pre-arranged Rule 10b5-1 trading plan.

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,335 shares of Class A Common Stock at a price of $20.29 per share on July 23, 2024, under a pre-arranged 10b5-1 trading plan.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. exercised stock options and sold shares of Class A Common Stock on July 23 and 24, 2024, according to a Form 4 filing with the SEC.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Irene Becklund, PAO of Hims & Hers Health, executed stock option exercises and sales of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,335 shares of Class A Common Stock at a price of $20.28 on July 9, 2024, according to a Form 4 filing with the SEC.

Melissa Baird, COO of Hims & Hers Health, executed stock option exercises and sales of Class A Common Stock between July 5th and July 9th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

CEO Andrew Dudum exercised stock options and sold shares of Hims & Hers Health, Inc. on July 3, 2024, according to a Form 4 filing with the SEC.

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. on June 24, 2024, according to a Form 4 filing with the SEC.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,335 shares of Class A Common Stock at a price of $22.18 per share on June 25, 2024, under a pre-arranged 10b5-1 trading plan.

Oluyemi Okupe, CFO of Hims & Hers Health, Inc., sold 11,546 shares of Class A Common Stock at an average price of $22.2146 on June 25, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CEO Andrew Dudum sold shares of Class A Common Stock on June 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, reports the vesting and disposal of restricted stock units to cover tax obligations, resulting in adjustments to their holdings of Class A Common Stock.

Irene Becklund, PAO of Hims & Hers Health, reports multiple transactions involving Class A Common Stock, including acquisitions, disposals, and option exercises, according to a Form 4 filing.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, reports the vesting of restricted stock units, subsequent tax withholding, and sale of shares under a pre-arranged trading plan.

Director David B. Wells reports the vesting and conversion of restricted stock units into Class A Common Stock.

Chief Medical Officer Patrick Harrison Carroll reports transactions involving Hims & Hers Health, Inc. Class A Common Stock, including the vesting of Restricted Stock Units (RSUs) and shares withheld for tax obligations.

Andrew Dudum, CEO of Hims & Hers Health, reports the vesting and settlement of restricted stock units and related tax withholding.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units on June 14, 2024, due to vesting of RSUs and tax withholding.

Chief Financial Officer of Hims & Hers Health, Oluyemi Okupe, reports the vesting and subsequent tax withholding of Class A Common Stock.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,510 shares of Class A Common Stock at a price of $21.47 per share on June 11, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. reports exercising stock options and selling Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Lynne Chou O'Keefe, a director of Hims & Hers Health, Inc., reported the vesting of 19,707 Restricted Stock Units (RSUs) on June 6, 2024, convertible to Class A Common Stock.

Director Delos M. Cosgrove reports the vesting of restricted stock units (RSUs) into Class A Common Stock of Hims & Hers Health, Inc.

Director David B. Wells reports the vesting and conversion of Restricted Stock Units (RSUs) into Class A Common Stock of Hims & Hers Health, Inc.

Director Andrea Perez Garcia reports vesting of restricted stock units into Class A Common Stock of Hims & Hers Health, Inc.